Latest Regulatory News

Page 61 of 877
Silver Mines Limited is progressing its Bowdens Silver Project development application with updated ecological surveys, while exploration intensifies at the Rockwell Prospect and Californian assets, supported by a solid cash position.
Maxwell Dee
Maxwell Dee
29 Apr 2026
Prodigy Gold has boosted the indicated resource at its Hyperion Gold Deposit by 70%, lifting total resources to 454,000 ounces and progressing key mining approvals and joint ventures.
Maxwell Dee
Maxwell Dee
29 Apr 2026
Actinogen Medical’s pivotal XanaMIA trial clears a key interim hurdle with the Data Monitoring Committee endorsing continuation, while a $16.8 million capital raise and non-dilutive funding bolster its balance sheet ahead of final results due November 2026.
Ada Torres
Ada Torres
29 Apr 2026
Zeotech pushed forward its AusPozz™ metakaolin commercialisation with extended and new MOUs, progressed key Toondoon project approvals amid rising contractor costs, and launched live methane control trials.
Maxwell Dee
Maxwell Dee
29 Apr 2026
Argent BioPharma secured a 48% stake in CannPal Animal Therapeutics, shipped its largest CannEpil® order to Ireland worth A$783,000, and filed a US provisional patent for its NanoBodies platform, underpinning its neuro-immune strategy and commercial growth.
Ada Torres
Ada Torres
29 Apr 2026
Bannerman Energy has locked in a landmark US$321.5 million strategic investment from CNNC Overseas Limited, enabling debt-free construction of its Etango Uranium Project and setting the stage for a Final Investment Decision in H2 2026.
Maxwell Dee
Maxwell Dee
29 Apr 2026
Volt Resources has secured a major extension and volume increase to its Bunyu graphite offtake agreement while progressing high purity graphite production and downstream refinery development in the US.
Maxwell Dee
Maxwell Dee
29 Apr 2026
Southern Palladium reported a doubling in chromite recoveries at its Bengwenyama project, prompting a redesign of the processing plant and pushing the DFS completion to late Q4 2026 amid drilling delays and enhanced metallurgical work.
Maxwell Dee
Maxwell Dee
29 Apr 2026
Emyria Limited is extending its Empax mental health clinic network into New South Wales through a new partnership with Matilda Nepean Private Hospital, increasing treatment capacity and national reach ahead of a planned Q3 2026 launch.
Ada Torres
Ada Torres
29 Apr 2026
Resonance Health reports strong cash flow and progress in clinical trials, with a record forward order pipeline for its Software-as-a-Medical-Device business and profitable trial site clinics.
Ada Torres
Ada Torres
29 Apr 2026
HyTerra Ltd is progressing its flagship Nemaha hydrogen project with a key production test planned for Q2 2026, while expanding its global footprint through strategic partnerships and a $7 million capital raise.
Maxwell Dee
Maxwell Dee
29 Apr 2026
Botanix Pharmaceuticals reported a 5% rise in Sofdra prescriptions in Q3 FY26 despite a dip in net revenue due to insurance deductible resets, strengthened by a $45 million capital raise and a new API supply deal with Piramal.
Ada Torres
Ada Torres
29 Apr 2026